Literature DB >> 26997100

Management of stage IIIA (N2) non-small cell lung cancer: A transatlantic perspective.

Gaetano Rocco1, Katie Nason2, Alex Brunelli3, Gonzalo Varela4, Thomas Waddell5, David R Jones6.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26997100     DOI： 10.1016/j.jtcvs.2016.01.035

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  14 in total

1.  Videothoracoscopic resection for lung cancer: moving towards a "standard of care".

Authors:  Tom Treasure
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

2.  The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung Cancer.

Authors:  Daniel C Thomas; Brian N Arnold; Joshua E Rosen; Michelle C Salazar; Frank C Detterbeck; Justin D Blasberg; Daniel J Boffa; Anthony W Kim
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

3.  Occult stage IIIA-N2 patients have excellent overall survival with initial surgery.

Authors:  Min P Kim; Arlene M Correa; Wayne L Hofstetter; Reza J Mehran; David C Rice; Jack A Roth; Ara A Vaporciyan; Garrett L Walsh; Jeremy J Erasmus; Stephen G Swisher
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

4.  National guideline concordance and outcomes for pathologic N2 disease in non-small cell lung cancer.

Authors:  Brian Mitzman; Thomas K Varghese; Kristine Kuchta; Seth B Krantz
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

Review 5.  N2-IIIA non-small cell lung cancer: a plea for surgery!

Authors:  Gilbert Massard; Stéphane Renaud; Jérémie Reeb; Nicola Santelmo; Anne Olland; Pierre-Emmanuel Falcoz
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

6.  Expression of engrailed homeobox 2 regulates the proliferation, migration and invasion of non-small cell lung cancer cells.

Authors:  Xiangxiao Lin; Xincun Liu; Cunqi Gong
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

7.  Systematic lymphadenectomy versus sampling of ipsilateral mediastinal lymph-nodes during lobectomy for non-small-cell lung cancer: a systematic review of randomized trials and a meta-analysis.

Authors:  Sahar Mokhles; Fergus Macbeth; Tom Treasure; Riad N Younes; Robert C Rintoul; Francesca Fiorentino; Ad J J C Bogers; Johanna J M Takkenberg
Journal:  Eur J Cardiothorac Surg       Date:  2017-06-01       Impact factor: 4.191

8.  How Effective Is Neoadjuvant Therapy Followed by Surgery for Pathologic Single-Station N2 Non-Small Cell Lung Cancer?

Authors:  Hari B Keshava; Kay See Tan; Joseph Dycoco; Jennifer Livschitz; Matthew J Bott; James Huang; Valerie W Rusch; James M Isbell; Daniela Molena; Manjit S Bains; David R Jones; Gaetano Rocco
Journal:  Semin Thorac Cardiovasc Surg       Date:  2020-08-25

Review 9.  Multimodality Treatment of Advanced Non-small Cell Lung Cancer: Where are we with the Evidence?

Authors:  Christopher M Jones; Alessandro Brunelli; Matthew E Callister; Kevin N Franks
Journal:  Curr Surg Rep       Date:  2018-02-08

10.  Prognostic Value of Tumor Size in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer.

Authors:  Chih-Yu Chen; Bing-Ru Wu; Chia-Hung Chen; Wen-Chien Cheng; Wei-Chun Chen; Wei-Chih Liao; Chih-Yi Chen; Te-Chun Hsia; Chih-Yen Tu
Journal:  J Clin Med       Date:  2020-05-01       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.